Implication of the melanocortin-3 receptor in the regulation of food intake
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The melanocortin system is well recognized to be involved in the regulation of food intake, body weight, and energy homeostasis. To probe the role of the MC3 in the regulation of food intake, JRH322-18 a mixed MC3 partial agonist/antagonist and MC4 agonist tetrapeptide was examined in wild type (WT) and melanocortin 4 receptor (MC4) knockout mice and shown to reduce food intake in both models. In the wild type mice, 2.0 nmol of JRH322-18 statistically reduced food intake 4hrs post icv treatment into satiated nocturnally feeding wild type mice. The same dose in the MC4KO mice significantly reduced cumulative food intake 24h post treatment. Conditioned taste aversion as well as activity studies support that the decreased food intake was not due to visceral illness. Since these studies resulted in loss-of-function results, the SHU9119 and agouti-related protein (AGRP) melanocortin receptor antagonists were administered to wild type as well as the MC3 and MC4 knockout mice in anticipation of gain-of-function results. The SHU9119 ligand produced an increase in food intake in the wild type mice as anticipated, however no effect was observed in the MC3 and MC4 knockout mice as compared to the saline control. The AGRP ligand however, produced a significant increase in food intake in the wild type as well as the MC3 and MC4 knockout mice and it had a prolonged affect for several days. These data support the hypothesis that the MC3 plays a subtle role in the regulation of food intake, however the mechanism by which this is occurring remains to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 4×
“The melanocortin 4 receptor (MC4) has been demonstrated to be involved in the regulation of food intake (Fan et al., 1997) and therefore has an impact on obesity (Huszar et al., 1997) in rodents and humans.”
BackgroundMethodInfluentialThe cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 1×
“The melanocortin 1 receptor (MC1) is clearly linked to the melanocortin agonist effects on pigmentation and animal coat coloration (Mountjoy et al., 1992).”
BackgroundModulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Cited by
Ericson, M. D., Schnell, S. M., Freeman, K. T., & Haskell-Luevano, C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.046 · Cited by 40
Self-citationPillot, B., Duraffourd, C., Bégeot, M., Joly, A., Luquet, S., Houberdon, I., Naville, D., Vigier, M., Gautier-Stein, A., Magnan, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019107 · Cited by 29
Adank, D. N., Lunzer, M. M., Lensing, C. J., Wilber, S. L., Gancarz, A. M., & Haskell-Luevano, C. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00330 · Cited by 18
Self-citation
Metadata
- Authors
- Irani, B. G., Xiang, Z., Yarandi, H. N., Holder, J. R., Moore, M. C., Bauzo, R. M., Proneth, B., Shaw, A. M., Millard, W. J., Chambers, J. B., Benoit, S. C., Clegg, D. J., & Haskell-Luevano, C.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 660
- Issue
- 1
- Pages
- 80-87
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1990572454
- Cited by
- 63
- References
- 3
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.